As part of a multi-year RWE initiative, AMCP Research Institute partnered with IQVIA, payers, pharmaceutical companies, and others to design payer-focused RWE standards that were published in JMCP in September, 2025.
AMCP sends letters to all 100 Senators supporting S. 974, the CREATES Act
On behalf of the Academy of Managed Care Pharmacy (AMCP), I am writing to express our strong support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974), bipartisan legislation designed to increase patient access to safe and affordable generic and biosimilar medicines and marketplace competition. AMCP was pleased that the bill continued to garner bipartisan support when it was voted out of the Judiciary Committee. We are seeking your support for the bill now that the bill is on the Senate Legislative Calendar.
Related
AMCP’s guidance translates CMS’s expectations for patient centered, evidence informed formulary decisions into practical steps payers can act on today without adding unnecessary burden to P&T workflows.
Metabolic diseases drive rising costs and disparities, yet evidence‑based care remains inconsistent. AMCP is advancing guidance, education, and collaboration to support aligned coverage, equitable access, and improved outcomes.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
